Effervescent and Chewing Tablet Market Report 2025

The effervescent and chewing tablet market size has grown rapidly in recent years. It will grow from $4.36 billion in 2024 to $4.88 billion in 2025 at a compound annual growth rate (CAGR) of 11.9%. The growth in the historic period can be attributed to increasing demand for fast-dissolving supplements, growing consumer awareness about nutritional deficiencies, growing fitness and wellness trends, rising self-medication practices, and increasing disposable income.

The effervescent and chewing tablet market size is expected to see rapid growth in the next few years. It will grow to $7.77 billion in 2029 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to growth in personalized nutrition demand, rising adoption of plant-based supplements, increasing focus on sustainable packaging, demand for immune-boosting supplements, and increasing awareness of eco-friendly products. Major trends in the forecast period include a rise in vegan and organic supplements, growth in clean-label effervescent products, a surge in demand for sugar-free formulations, the popularity of single-serve effervescent formats, and a focus on enhanced bioavailability of ingredients.

The forecast of 12.3% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of pharmaceutical-grade effervescent bases and chewable tablet excipients sourced from Germany and India, thereby delaying over-the-counter medication production and raising consumer healthcare costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of digestive disorders is projected to drive the growth of the effervescent and chewing tablet market in the foreseeable future. The rise in digestive issues is largely attributed to factors such as unhealthy dietary habits, high stress levels, sedentary lifestyles, an overreliance on medications, and a growing consumption of processed foods. Effervescent and chewing tablets offer rapid and convenient relief for digestive disorders such as indigestion, bloating, and heartburn, making them a preferred option for managing mild gastrointestinal discomfort. For example, the Impact of IBD Report 2023, published by the IBD Clinical and Research Centre in September 2023, noted that over 320,000 individuals in Canada have inflammatory bowel disease (IBD), with a prevalence of 825 per 100,000 people. This figure is expected to rise by 2.44% annually, projecting that by 2035, approximately 470,000 Canadians will be living with IBD. Thus, the rising incidence of digestive disorders is significantly fueling the growth of the effervescent and chewing tablet market.

Key players in the effervescent and chewing tablet markets are concentrating on developing innovative moisture-resistant manufacturing techniques to maintain their competitive edge. Moisture-resistant manufacturing processes are designed to protect products from damage or degradation due to moisture exposure, thereby ensuring durability and reliability. For instance, in April 2022, Health Innovations Ltd., a UK-based healthcare supplement company, launched EfferShield, a groundbreaking manufacturing technology for effervescent products. This patented innovation minimizes reliance on conventional plastic tubes, offering a more sustainable alternative. EfferShield features a specialized moisture-resistant barrier that ensures product stability while facilitating the creation of new formulations. It also supports eco-friendly packaging options, such as pouches and stick packs, making it suitable for single-use applications.

In January 2022, Kelso Pharma, a UK-based specialty pharmaceutical company, acquired Stirling Anglian Pharmaceuticals Ltd. for an undisclosed amount. This acquisition aims to enhance Kelso Pharma's platform in the UK for expanding its pan-European specialty pharmaceutical business through further acquisitions, product licensing, and innovations in cost-effective, patient-focused medicines. Stirling Anglian Pharmaceuticals Ltd. specializes in providing effervescent and chewing tablets.

Major companies operating in the effervescent and chewing tablet market are Pfizer Inc., Merck & Co. Inc., Bayer AG, Sanofi SA, Abbott Laboratories, Boehringer Ingelheim, Teva Pharmaceutical Industries, Amway Corp., Sun Pharmaceutical Industries Ltd., Herbalife International Inc., Dr Reddy's Laboratories Ltd., Leo Nutriscience, Bliss GVS Pharma Limited, Amerilab Technologies Inc., Tower Laboratories Ltd., Vitabiotics Ltd., Losan Pharma GmbH, Biocaro Pharmaceutical, Nutra Healthcare Private Limited, Vovantis Laboratories Pvt. Ltd., BHI Biohealth International GmbH, Nutrilo GmbH, PharmaEstica Manufacturing OÜ, The Himalayan Organics, FixupHealth, The Vitamin Company.

North America was the largest region in the effervescent and chewing tablet market in 2023. The regions covered in the effervescent and chewing tablet market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the effervescent and chewing tablet market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The effervescent and chewing tablet market consists of sales of vitamin and mineral supplements, pain relief tablets, and gastrointestinal relief products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the pharmaceutical sector. Companies are grappling with higher costs on imported active pharmaceutical ingredients (APIs), glass vials, and laboratory equipment - many of which have limited alternative sources. Generic drug manufacturers, already operating with minimal profit margins, are particularly affected, with some scaling back production of low-margin medications. Biotech firms are also experiencing delays in clinical trials due to shortages of specialized reagents linked to tariffs. In response, the industry is shifting API production to regions like India and Europe, building up inventory reserves, and advocating for tariff exemptions on essential medicines.

The effervescent and chewing tablet market research report is one of a series of new reports that provides effervescent and chewing tablet market statistics, including effervescent and chewing tablet industry global market size, regional shares, competitors with a effervescent and chewing tablet market share, detailed effervescent and chewing tablet market segments, market trends and opportunities, and any further data you may need to thrive in the effervescent and chewing tablet industry. This effervescent and chewing tablet market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Effervescent and chewing tablets are oral dosage forms designed for rapid disintegration and absorption. Effervescent tablets dissolve in water, releasing carbon dioxide to create a fizzy solution that enhances absorption speed. In contrast, chewing tablets are formulated to be chewed before swallowing, allowing for direct contact with saliva and a quicker onset of action.

The primary types of effervescent and chewing tablets are effervescent tablets and chewing tablets. An effervescent tablet is designed to dissolve in water, releasing carbon dioxide to form a fizzy solution, and is commonly used for fast-acting medications, nutritional supplementation, and electrolyte replacement. These products are distributed through various channels, including pharmacies and drug stores, supermarkets and hypermarkets, online retailers, and healthcare practitioners. They serve diverse applications such as healthcare, nutritional supplementation, weight management, and cosmetics, catering to a wide range of users, including adults, children, seniors, and athletes.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.